| # | Drug | Count |
|---|---|---|
| 0 | CYCLOSPORINE | 18 |
| 1 | CYCLOPHOSPHAMIDE | 17 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 17 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 17 |
| 4 | IMATINIB | 17 |
| 5 | DOXORUBICIN | 15 |
| 6 | VENETOCLAX | 14 |
| 7 | DASATINIB | 11 |
| 8 | LENALIDOMIDE | 11 |
| 9 | AZACITIDINE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | STREPTOZOCIN | 4 | 0.0174 |
| 1 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 3 | 0.0029 |
| 2 | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | 1 | 0.0015 |
| 3 | AMINOCAPROIC ACID | 1 | 0.0012 |
| 4 | DASATINIB | 11 | 0.0012 |
| 5 | DECITABINE | 4 | 0.0009 |
| 6 | IDARUBICIN HYDROCHLORIDE | 1 | 0.0009 |
| 7 | BOSUTINIB | 7 | 0.0008 |
| 8 | TREOSULFAN | 2 | 0.0007 |
| 9 | MITOXANTRONE HYDROCHLORIDE | 4 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 23 |
| 1 | Calcineurin Inhibitor Immunosuppressant [EPC] | 18 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 18 |
| 3 | BCL-2 Inhibitor [EPC] | 14 |
| 4 | Corticosteroid [EPC] | 11 |
| 5 | Thalidomide Analog [EPC] | 11 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 9 |
| 7 | Kinase Inhibitor [EPC] | 8 |
| 8 | Microtubule Inhibitor [EPC] | 6 |
| 9 | Azole Antifungal [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Erythroid Maturation Agent [EPC] | 1 | 0.0004 |
| 1 | BCL-2 Inhibitor [EPC] | 14 | 0.0002 |
| 2 | Calcineurin Inhibitor Immunosuppressant [EPC] | 18 | 0.0001 |
| 3 | Thrombopoietin Receptor Agonist [EPC] | 2 | 0.0001 |
| 4 | Iron Chelator [EPC] | 3 | 0.0001 |
| 5 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 6 | Alkylating Drug [EPC] | 23 | 0.0001 |
| 7 | Complement Inhibitor [EPC] | 4 | 0.0001 |
| 8 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 18 | 0.0001 |